Search
for
Sort by
Research 61–90 of 325
- Migration Inhibitory Factor in Conditioned Medium from Human Umbilical Cord Blood-Derived Mesenchymal Stromal Cells Stimulates Hair Growth
- Pathological findings in a case of stiff person syndrome with anti‐GAD antibodies
- Monotherapy for Alopecia Areata: A Systematic Review and Network Meta-Analysis
- Characteristics and Alternative Treatment Outcomes of Antimalarial-Refractory Cutaneous Lupus Erythematosus
- Intermittent and Persistent Type 2 lupus: patient perspectives on two distinct patterns of Type 2 SLE symptoms
- Applications of Marine Organism-Derived Polydeoxyribonucleotide: Its Potential in Biomedical Engineering
- Gut microbiota in alopecia areata
- Topical Treatments for Scalp Psoriasis
- Cardiodermatology: the heart of the connection between the skin and cardiovascular disease
- Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis
- Symptom management in inflammatory bowel disease
- Use of H-1 Antihistamine in Dermatology: More than Itch and Urticaria Control: A Systematic Review
- Hyperadrenocorticism in Ferrets
- Thermographic Follow-up of a Mild Case of Herpes Zoster
- Taste disorders and alopecia in myasthenia gravis
- Sublingual minoxidil for the treatment of male and female pattern hair loss: a randomized, double‐blind, placebo‐controlled, phase 1B clinical trial
- Patient-Reported Hair Loss and Its Impacts as Measured by the Alopecia Areata Patient Priority Outcomes Instrument in Patients Treated with Ritlecitinib: The ALLEGRO Phase 2b/3 Randomized Clinical Trial
- Ottawa, Ontario, Canada, February 13–16, 2013
- Frontotemporal dementia with parkinsonism presenting as posterior cortical atrophy
- Impact of Previous Alopecia Areata Treatment on Efficacy Responses up to Week 48 Following Ritlecitinib Treatment: A Post Hoc Analysis
- Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review
- Abstracts
- Diagnostik und Therapie der kutanen Androgenisierung im klimakterischen Übergang sowie in der Peri- und Postmenopause: Hirsutismus und Alopezie
- Deep phenotyping of skin tissue remodeling in patients with systemic sclerosis treated with CD19-CAR T cells
- Hair Oils May Worsen Seborrheic Dermatitis in Black Patients
- Industry update: the latest developments in the field of therapeutic delivery, July 2018
- A Cost-per-Responder Analysis of Ritlecitinib vs Baricitinib in Severe Alopecia Areata
- Patient Profile and Treatment Characteristics of Adults and Adolescents Prescribed Ritlecitinib for Alopecia Areata in the USA
- Case Report: Bimekizumab for dissecting cellulitis of the scalp
- How Long to Treat to Achieve Desired Treatment Outcomes with Baricitinib 4 mg in Severe Alopecia Areata: Evidence-based Approach